Study finds partially-efficacious vaccine can offer a fundamental solution to the pandemic and at high cost-effectiveness

​​​Several SARS-CoV-2 vaccine candidates are currently in the pipeline. In this context and with the aim of informing SARS-CoV-2 vaccine development, licensure, decision-making, and implementation, Dr. Ghina Mumtaz and ​Sarah Al-Omari from the Faculty of Health Sciences at the American University of Beirut ​along with experts from ​Cornell University and Qatar University published a new study entitled "Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses."

Through determining key preferred vaccine product characteristics and associated population-level impact, the study suggests that even a partially-efficacious vaccine can offer a fundamental solution to control SARS-CoV-2 infection and at high cost-effectiveness.

Read the full study HERE​

Contact Us

For various questions, please try contacting us via social media first!
read more

Privacy Statement

We take data privacy seriously and adhere to all applicable data privacy laws and regulations.
read more

Copyright and Disclaimer

Written permission is needed to copy or disseminate all or part of the materials on the AUB website.
read more

Title IX, Non-Discrimination, and Anti-Discriminatory Harassment

AUB is committed to providing a safe, respectful, and inclusive environment to all members of its community.
read more